This article has been updated with comments from PQDNA CEO Andre Gous.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has notified three more companies marketing genetic tests directly to consumers that their tests make medical claims, appear to qualify as medical devices, and should be regulated.

The firms that received letters include Lumigenix, American International Biotechnology Services (AIBiotech), and Precision Quality DNA (PQDNA).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.